The North Carolina State Health Plan provides a striking example of the financial implications involved, estimating that continuing to cover brand GLP-1s for weight loss in 2024 would require increasing premiums by $48.50 per subscriber per month for all members, not just GLP-1 users
Bagley JA, Reumann D, Bian S, Lvi-Strauss J, Knoblich JA
Zofran is FDA-approved to treat and prevent nausea from surgery, chemotherapy, and radiation, but it's commonly prescribed off-label to treat all types of nausea
It can occur during many medically supervised weight-loss programmes
A growing body of experimental evidence links DKD pathogenesis and progression with intestinal dysbiosis, gut barrier disruption, and elevated levels of gut-derived microbial toxins (223)